Results of the association between sTNFR2 concentrations ≥1.608 ng/mL and renal composite events stratified by age, sex, systolic blood pressure, eGFR, UACR, and the use of RAS inhibitors.

Results of the association between sTNFR2 concentrations ≥1.608 ng/mL and renal composite events stratified by age, sex, systolic blood pressure, eGFR, UACR, and the use of RAS inhibitors.按年龄、性别、收缩压、估算肾小球滤过率（estimated Glomerular Filtration Rate, eGFR）、尿白蛋白/肌酐比值（Urinary Albumin-to-Creatinine Ratio, UACR）以及肾素-血管紧张素系统抑制剂（Renin-Angiotensin System Inhibitors, RAS抑制剂）使用情况进行分层分析的可溶性肿瘤坏死因子受体2（soluble Tumor Necrosis Factor Receptor 2, sTNFR2）浓度≥1.608 ng/mL与肾脏复合终点事件之间的关联研究结果